Document is current
Any future updates will be listed below
-
Authors
Valibeygi, Adib http://orcid.org/0000-0002-6900-4291
Davoodi, Ali
Dehghan, Azizallah http://orcid.org/0000-0002-7345-0796
Vahid, Farhad http://orcid.org/0000-0002-7380-3790
Hébert, James R. http://orcid.org/0000-0002-0677-2672
Farjam, Mojtaba http://orcid.org/0000-0003-4826-2846
Homayounfar, Reza http://orcid.org/0000-0001-5398-9519
- License Information
-
More Information
Article History
Received: 29 September 2022
Accepted: 23 June 2023
First Online: 11 July 2023
Declarations
:
: The study protocol and procedures were in accordance with the ethical standards of the 1964 Helsinki Declaration. Written and informed consent was obtained from each participant to enter the first phase of the cohort study. The study protocol has been approved by the ethics committee of Fasa University of Medical Sciences IR.FUMS.REC.1399.138.
: Not applicable.
: Dr. James R. Hébert owns a controlling interest in Connecting Health Innovations LLC (CHI), a company that has licensed the right to his invention of the dietary inflammatory index (DII®) from the University of South Carolina in order to develop computer and smartphone applications for patient counseling and dietary intervention in clinical settings. Dr. Nitin Shivappa is an employee of CHI. Other authors have no competing interest to declare.
